Polypill Prevention Programme

Polypill Ltd is a UK-based healthcare company that manages the Polypill Prevention Programme, an initiative focused on the primary prevention of cardiovascular disease. Founded by Professor Sir Nicholas Wald, who first proposed the polypill concept in 2003, the company provides a service that includes medical consultation and the provision of a fixed-dose combination medication. The polypill typically combines a statin with blood pressure-lowering agents to significantly reduce the risk of heart attacks and strokes in at-risk individuals. The programme emphasizes a simplified, evidence-based approach to preventative medicine, aiming to improve patient adherence and public health outcomes. By integrating multiple medications into a single daily dose, the company seeks to lower the barriers to effective long-term cardiovascular risk management.